Caplin Point Laboratories Ltd
Caplin Point Laboratories Ltd (CAPLIPOINT) last traded at ₹2,471, a market capitalisation of ₹18,780 crore, on a P/E of 28.3. Over the past 52 weeks the stock has ranged between ₹1,500 and ₹2,700. Caplin Point Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹610 crore and net profit of ₹179 crore. The next scheduled event is a record date on 18 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Caplin Point Laboratories Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Caplin Point Laboratories Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹610 cr, up 19.6% from ₹510 cr a year earlier. Net profit was ₹179 cr, up 18.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 483 | 493 | 502 | 510 | 534 | 543 | 600 | 610 |
| Expenses | 318 | 331 | 334 | 332 | 345 | 353 | 396 | 397 |
| Operating profit | 165 | 162 | 168 | 178 | 189 | 190 | 204 | 213 |
| OPM % | 34% | 33% | 33% | 35% | 35% | 35% | 34% | 35% |
| Other income | 21 | 31 | 26 | 23 | 30 | 34 | 28 | 34 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 17 | 16 | 17 | 16 | 18 | 19 | 19 | 22 |
| Profit before tax | 168 | 177 | 177 | 184 | 201 | 204 | 213 | 225 |
| Tax % | 22% | 21% | 18% | 18% | 20% | 19% | 19% | 20% |
| Net profit | 131 | 140 | 145 | 151 | 160 | 166 | 173 | 179 |
| EPS (₹) | 17.21 | 18.28 | 18.76 | 20.10 | 20.32 | 21.56 | 22.38 | 23.27 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Caplin Point Laboratories Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1,061 | 1,269 | 1,467 | 1,694 | 1,937 | 2,187 | 2,287 |
| Operating profit | 329 | 395 | 442 | 552 | 651 | 761 | 797 |
| OPM % | 31% | 31% | 30% | 33% | 34% | 35% | 35% |
| Net profit | 251 | 308 | 377 | 461 | 541 | 650 | 678 |
| EPS (₹) | 32.03 | 39.56 | 49.57 | 60.19 | 70.56 | 84.36 | 87.53 |
TTM is the trailing twelve months to the most recent quarter.
Caplin Point Laboratories Ltd growth and returns
- 10 Years
- 25%
- 5 Years
- 16%
- 3 Years
- 14%
- TTM
- 15%
- 10 Years
- 30%
- 5 Years
- 22%
- 3 Years
- 20%
- TTM
- 18%
- 10 Years
- 26%
- 5 Years
- 28%
- 3 Years
- 35%
- 1 Year
- 15%
- 10 Years
- 25%
- 5 Years
- 23%
- 3 Years
- 22%
- Last Year
- 21%
Caplin Point Laboratories Ltd shareholding pattern
Promoters held 70.57% at Jun 2026, broadly unchanged since Jun 2025. FIIs 5.76% and DIIs 2.49%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 70.56% | 70.56% | 70.56% | 70.56% | 70.57% | 70.57% | 70.57% | 70.57% |
| FIIs | 3.71% | 4.86% | 5.73% | 6.16% | 6.51% | 6.58% | 6.15% | 5.76% |
| DIIs | 1.83% | 2.11% | 2.00% | 2.22% | 2.10% | 2.05% | 2.14% | 2.49% |
| Public | 23.93% | 22.48% | 21.72% | 21.06% | 20.82% | 20.81% | 21.14% | 21.19% |
| No. of shareholders | 96,123 | 92,702 | 96,387 | 94,169 | 93,753 | 93,705 | 93,896 | 94,385 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Caplin Point Laboratories Ltd events
The next scheduled event is a record date on 18 Sept 2026.
- Record dateRecord date for 35th AGM and payment of final dividend
- AGM35th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Caplin Point Laboratories Ltd corporate filings
- Completion of Unannounced USFDA Inspection at the facility of Caplin Steriles Limited (Company''s subsidiary)Company Updatemedium impact
Cruxal's analysis: Caplin Point Laboratories announced that its subsidiary, Caplin Steriles Limited, has…
Read the full analysis - Transcript for Earnings call- Q1- FY 2026-27Company Updatelow impact
Cruxal's analysis: Caplin Point Laboratories Limited has formally filed the transcript of its Q1 FY 2026-27…
Read the full analysis - Audio Recording of Earnings call for the Quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Caplin Point Laboratories Limited has formally filed the audio recording of its Q1 FY…
Read the full analysis - The Board of Director in its meeting held today, August 12, 2026, approved the appointment of directors.Company Updatelow impact
Cruxal's analysis: Caplin Point Laboratories Limited has announced the re-appointment of Dr. Sridhar Ganesan…
Read the full analysis - Record date for Final Dividend is September 18, 2026Corp. Actionlow impact
Cruxal's analysis: Caplin Point Laboratories Limited has scheduled its 35th Annual General Meeting for…
Read the full analysis - Board meeting outcome for meeting held on August 12, 2026Board Meetinghigh impact
Cruxal's analysis: Caplin Point Laboratories Limited delivered a robust performance for the quarter ended…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Caplin Point Laboratories Ltd
Cruxal reads every Caplin Point Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.